Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)

13 novembre 2026 aggiornato da: University Hospital, Limoges

A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital

SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.

The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).

A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.

Panoramica dello studio

Descrizione dettagliata

Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.

Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.

Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.

Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.

This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.

Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.

Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.

Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.

Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.

The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.

Tipo di studio

Osservativo

Iscrizione (Stimato)

70

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

      • Limoges, Francia, 87042
        • Reclutamento
        • Chu Limoges
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.

Descrizione

Inclusion Criteria:

  • Age 18 years or older.
  • Patients undergoing elective cholecystectomy.
  • Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
  • Patients able to complete questionnaires independently or with the assistance of a caregiver.
  • Patients covered by a health insurance scheme.
  • Patients who have not objected to participation in the study.

Exclusion Criteria:

  • Patients undergoing emergency surgery.
  • Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
  • Patients with a history of chronic gastrointestinal disease.
  • Patients with known gallbladder cancer.
  • Patients scheduled for open laparotomy.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Patients undergoing elective cholecystectomy

Adult patients undergoing elective cholecystectomy at Limoges University Hospital

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Proportion of patients with a visual analogue scale (VAS) pain
Lasso di tempo: From two hours after surgery to four weeks postoperatively.

Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

From two hours after surgery to four weeks postoperatively.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Proportion of patients with a VAS pain score
Lasso di tempo: Two hours after surgery.

Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy.

Two hours after surgery.
Proportion of patients experiencing early postoperative complications
Lasso di tempo: Up to four weeks after surgery.

Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification.

Up to four weeks after surgery.
Description of intraoperative pain management techniques
Lasso di tempo: During surgery

Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block .

For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable.

During surgery
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Lasso di tempo: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2)

Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
Change in the EQ-5D-5L visual analogue scale (VAS)
Lasso di tempo: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2).

Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
Description of patient-reported experience using the study-specific PREMS questionnaire
Lasso di tempo: Postoperative assessment at 3 to 6 weeks (T2)

Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item.

Postoperative assessment at 3 to 6 weeks (T2)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Niki CHRISTOU, Professor, University Hospital, Limoges

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

13 giugno 2025

Completamento primario (Stimato)

13 giugno 2027

Completamento dello studio (Stimato)

13 giugno 2028

Date di iscrizione allo studio

Primo inviato

30 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

13 novembre 2026

Primo Inserito (Effettivo)

17 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi